TL;DR
Get workout gear delivered free — and shop member deals
- Fast, free delivery on millions of items
- Access to Prime Big Deal Days deals on October 6–7
- Prime Video, Amazon Music and more included
Team Select Home Care says its CareSight AI platform now covers 100% of its patient census through three models focused on respiratory issues, cardiac conditions and infection detection. Company data show hospitalization rates fell 14.9% year over year from April through August 2026; the figures are company-reported and have not been independently verified in the source report.
Team Select Home Care says every patient in its census is covered by at least one CareSight AI model. The Phoenix-based provider also shared five months of outcome data with Home Health Care News showing a reported 14.9% decline in hospitalizations. The source report does not specify the exact months or establish that the comparison was over a full year; it also does not describe an independent evaluation of the figures.
CareSight uses more than a decade of Team Select patient records and monitors up to eight vital signs in real time, alongside nurse notes and changes in a patient’s condition. The provider says the system flags patterns that may signal clinical decline. Its three models address respiratory issues, cardiac conditions and infection risk, with every patient now covered by at least one model, according to the company.
Team Select has developed models for respiratory patients, cardiac conditions and infection detection. President and CEO Fred Johnson told Home Health Care News that developing the respiratory model took three years, the cardiac model six months and the infection model 90 days. The source report does not specify the order in which the models were developed or explain why the infection model was created.
Johnson shared five months of outcome data, and Team Select reported a 14.9% decline in hospitalizations. The source report does not specify the exact months covered or provide the underlying counts, patient-level results or details about how the rate was calculated. The percentage should therefore be read as a company-reported measure rather than an independently confirmed outcome.
Hospital Data May Shape Payer Deals
The reported reduction could help Team Select make a case to health plans for contracts that tie some payment to patient outcomes. Johnson said the company expects CareSight data to support value-based contracting, in which additional payment depends on meeting agreed measures such as reduced hospitalizations or lower total care costs. The provider is also redeveloping payer scorecards to show hospitalization and emergency-department visit ratios for a payer’s patients, along with patient satisfaction measures and industry comparisons.
That strategy matters as home-health providers seek ways to demonstrate value beyond the number of visits delivered, particularly when fee-for-service rate increases are difficult to secure. The reported result does not establish that the AI platform alone caused the decline, but it gives Team Select a metric it says it can bring into payer negotiations. Whether payers adopt contracts based on these measures, and on what terms, was not specified.
For patients and families, the company’s stated goal is to identify deterioration early enough for clinicians to respond before a hospital visit is needed. That potential is especially relevant to Team Select’s medically complex pediatric patients and older adults receiving care at home. The reported five-month comparison, however, does not establish the effect for any individual patient or show whether the change will persist.
As an affiliate, we earn on qualifying purchases.
Three Models Built From Patient Records
Team Select serves medically complex children and seniors in the home and operates in 16 states. Private equity firm Court Square Capital Partners invested in the company in 2023. Team Select launched CareSight in 2025, drawing on more than a decade of its own patient data.
The initial respiratory model did not apply across all diagnoses. Johnson said the company reviewed which conditions and combinations of conditions were associated with the most hospitalizations, then began with respiratory care, an area where the company had high-acuity experience. After adding the cardiac model, Team Select said about 65% of patients were covered by one of the two models. The infection model brought reported coverage to the full census.
The company also adjusted how CareSight handles alerts. Johnson said the early version produced too many false positives, including alerts for readings that were unusual against standard ranges but normal for a particular patient. Team Select added a patient-specific model that compares readings with an individual’s historical baseline, which the company says reduces unnecessary alerts to clinicians.
“I knew that if we could do this, not only would it be a long-lasting competitive advantage … [it] would significantly decrease those hospitalizations even further.”
— Fred Johnson, Team Select president and CEO, speaking to Home Health Care News
home health care vital signs monitor
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
How the Reported Decline Was Measured
The source report attributes the 14.9% decline to data shared by Team Select, but does not detail the number of hospitalizations, the number of patients included, the precise rate calculation or adjustments for changes in patient mix. It also does not identify an outside evaluator or provide a comparison group. The figures therefore show what the company reported for two five-month periods, not proof that CareSight caused the change.
Johnson said Team Select’s hospitalization rate had already been low compared with the industry before CareSight launched. He cited a seven-state Medicaid claims study commissioned by the company, which he said found a monthly 30-day hospitalization rate of 3% to 8% for Team Select, versus an industry average of 10% to 20% per month. The report does not provide the study itself or enough methodological detail to assess how those comparisons were made.
It is also unclear whether the company’s new payer scorecards or value-based contracts have been adopted by health plans, and what performance thresholds or financial terms such arrangements might use. The reported full-census coverage describes whether patients are assigned to at least one model; it does not by itself establish that every alert leads to intervention or prevents a hospital admission.
As an affiliate, we earn on qualifying purchases.
A Diabetes Model Is in Development
Team Select is developing a fourth CareSight model focused on diabetes, according to the source report. The company has not announced a launch date, detailed the model’s intended measures or said how it will assess performance after deployment.
The provider also plans to continue pursuing value-based agreements and rebuilding payer scorecards, Johnson told Home Health Care News. The next meaningful evidence will include whether health plans adopt those arrangements and whether future data show that the reported hospitalization trend continues. No timeline for new outcome reporting or payer decisions was provided.
AI-based hospital readmission reduction tools
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Key Questions
What did Team Select report?
Team Select said CareSight AI now covers its full patient census and that hospitalizations fell 14.9% year over year from April through August 2026. The figures were shared by the company with Home Health Care News.
What does CareSight monitor?
The platform uses patient records to monitor up to eight vital signs, nurse notes and changes in condition. Its three current models address respiratory issues, cardiac conditions and infection risk, according to Team Select.
Has the 14.9% decline been independently verified?
The source report presents the percentage as company data. It does not describe an independent audit, provide underlying counts or explain the full calculation, so the decline has not been independently established in the material provided.
Did CareSight cause fewer hospitalizations?
The reported comparison does not establish causation. It shows a year-over-year change during a period when the platform’s models were in place, but the report does not provide a comparison group or analysis isolating CareSight’s effect from other factors.
What is Team Select developing next?
Team Select is building a fourth model focused on diabetes. The company has not announced when it will be ready or provided outcome data for that model.
Source: rss
Halloween Picks
halloween
As an affiliate, we earn on qualifying purchases.
